Glembatumumab vedotin for patients with metastatic, gpNMB overexpressing, triple-negative breast cancer (“METRIC”): a randomized multicenter study
- Vahdat, L.T.
- Schmid, P.
- Forero-Torres, A.
- Blackwell, K.
- Telli, M.L.
- Melisko, M.
- Möbus, V.
- Cortes, J.
- Montero, A.J.
- Ma, C.
- Nanda, R.
- Wright, G.S.
- He, Y.
- Hawthorne, T.
- Bagley, R.G.
- Halim, A.-B.
- Turner, C.D.
- Yardley, D.A.
Revista:
npj Breast Cancer
ISSN: 2374-4677
Any de publicació: 2021
Volum: 7
Número: 1
Tipus: Article